312 results
Page 2 of 16
8-K
EX-99.1
r37tbax6 em7z3rzisv
7 Nov 23
Cassava Sciences Reports Third Quarter 2023 Financial and Operating Results
9:08am
8-K
EX-3.4
fav6i
13 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:17pm
8-K
EX-99.1
ka6wit376ql6eib
3 Aug 23
Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates
9:12am
8-K
EX-99.1
3hxjvi3uwm 4j862ent
5 Jul 23
Other Events
9:25am
8-K
EX-1.1
t3a5mkymb82n
1 May 23
Entry into a Material Definitive Agreement
5:26pm
424B5
kx2yq18p98yv
1 May 23
Prospectus supplement for primary offering
5:26pm
S-3ASR
s36 izjrl
1 May 23
Automatic shelf registration
4:01pm
8-K
EX-99.1
fx7z9 qu3
1 May 23
Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates
9:05am
8-K
EX-10.1
x4qlmyz
22 Nov 22
Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock
12:49pm
8-K
EX-99.2
qmeg109zoyp7va6dmzi
22 Nov 22
Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock
12:49pm
8-K
EX-99.1
a8xog8ujiz5bk7u
22 Nov 22
Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock
12:49pm
424B5
zt1sv1
21 Nov 22
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
oe040m2t4fqqz6d9oon2
7 Nov 22
Cassava Sciences Reports Third Quarter Financial Results for 2022 and Business Updates
9:09am
8-K
66ypnl42x27wcxkhaj8
27 Oct 22
Cassava Sciences Announces Expansion of Leadership Team
4:03pm
8-K
EX-10.1
kiuqm8stalqsiphm7a2t
27 Oct 22
Cassava Sciences Announces Expansion of Leadership Team
4:03pm